 Opioid-Related Disorders
"Opioid-Related Disorders" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders related or resulting from abuse or mis-use of opioids.
| Descriptor ID |
D009293
|
| MeSH Number(s) |
C25.775.675 F03.900.675
|
| Concept/Terms |
Opioid-Related Disorders- Opioid-Related Disorders
- Disorder, Opioid-Related
- Opioid Abuse
- Abuse, Opioid
- Abuses, Opioid
- Opioid Abuses
- Opiate Abuse
- Abuse, Opiate
- Abuses, Opiate
- Opiate Abuses
Opiate Dependence- Opiate Dependence
- Dependence, Opiate
- Opiate Addiction
- Addiction, Opiate
|
Below are MeSH descriptors whose meaning is more general than "Opioid-Related Disorders".
Below are MeSH descriptors whose meaning is more specific than "Opioid-Related Disorders".
This graph shows the total number of publications written about "Opioid-Related Disorders" by people in this website by year, and whether "Opioid-Related Disorders" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 | | 2003 | 0 | 1 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 3 | 0 | 3 | | 2007 | 1 | 2 | 3 | | 2008 | 0 | 2 | 2 | | 2010 | 3 | 0 | 3 | | 2011 | 2 | 0 | 2 | | 2012 | 2 | 0 | 2 | | 2013 | 4 | 0 | 4 | | 2014 | 8 | 0 | 8 | | 2015 | 7 | 0 | 7 | | 2016 | 11 | 3 | 14 | | 2017 | 15 | 2 | 17 | | 2018 | 20 | 10 | 30 | | 2019 | 30 | 10 | 40 | | 2020 | 38 | 1 | 39 | | 2021 | 36 | 2 | 38 | | 2022 | 48 | 0 | 48 | | 2023 | 48 | 0 | 48 | | 2024 | 26 | 3 | 29 | | 2025 | 30 | 1 | 31 | | 2026 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Opioid-Related Disorders" by people in Profiles.
-
Gold CM, Sarathy L, Congdon J, Wood KE, Kendrick-Allwood S, Cummings CL, Lee M, Christopher Golden W, Chung EK. Neonatal Toxicology Testing: Ethical Considerations for Pediatricians. Hosp Pediatr. 2026 Jan 01; 16(1):e64-e73.
-
Miller SE, Dukes KA, Damato-MacPherson C, Psaros C, Scott NA, Taylor JL, Muroff J, Winter MR, Skiba LE, Lugo H, Cruz R, Ruiz-Mercado G, Crawford ND, Mayer KH, Assoumou SA. Pre-exposure prophylaxis (PrEP) and medications for opioid use disorder for persons who inject drugs: the CHORUS?+?randomized controlled trial study protocol. Addict Sci Clin Pract. 2025 Dec 25; 21(1):17.
-
Amura CR, Techau A, Ritchie ND, Sorrell TR, Weber M, Kwan BM, Morrato EH, Cook PF. Planning for implementation scale-up of a medication for opioid use disorder program across rural Colorado: Ensuring fit to context. Eval Program Plann. 2026 Apr; 115:102749.
-
Nunes JC, Costa GPA, De Aquino JP, Adinoff B. Expanding Access to Buprenorphine and Methadone: Global Perspectives and Policy Recommendations. Subst Use Addctn J. 2026 Apr; 47(2):595-610.
-
Calcaterra SL, Weimer MB, Grimm E, Scherbak Y, Abdel Galil R, Berger O, Bowman LA, Nesbit SA, Barany A, Buresh ME. Leveraging the 72-Hour Rule Change to Support Transition From Hospital to Opioid Treatment Program. JAMA Netw Open. 2025 Nov 03; 8(11):e2544996.
-
Guan X, Jurecka C, Padmanabhan P, Yamkovoy K, Christine PJ, Binswanger IA, Glanz JM, Kline DM, Barocas JA. Impact of increased criminal penalties for fentanyl possession on initiation and retention on medications for opioid use disorder in Colorado. Int J Drug Policy. 2025 Dec; 146:105037.
-
Pytell JD, Pales D, Simon C, Beaudoin J, Osman AMY, Svoboda E, Christine PJ, Matlock D, Schwartz R, Binswanger IA. Systematic review of patient-reported outcome measures for opioid use disorder recovery. Addiction. 2026 Mar; 121(3):488-498.
-
Chambers LC, Giguere T, Welwean RA, Peachey AM, Wiehe SE, Aalsma MC, Ranney ML, Beaudoin FL. An evaluation of paid social media advertising and traditional advertising for addiction research recruitment. Drug Alcohol Depend. 2025 Dec 01; 277:112923.
-
Ostrowski SJ, Adkins A, Goldfarb D, Kukowski M, Stratton D, Barton DJ, Pizon AF. Transdermal buprenorphine patch-facilitated induction of sublingual buprenorphine in hospitalized patients receiving full agonist opioids: a retrospective cohort study. Clin Toxicol (Phila). 2025 Nov; 63(11):897-905.
-
Hall TL, Fernald DH, Jiang V, Curcija K, LeMaster JW, Westfall JM, Nease DE, Zittleman L. Induction of Medication for Opioid Use Disorder in Primary Care. J Am Board Fam Med. 2025 Sep 15; 38(3):539-550.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|